Impact Biomedical (IBO) Interest Expenses (2022 - 2026)

Impact Biomedical (IBO) has reported Interest Expenses for 5 consecutive years, with $67000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Interest Expenses fell 74.23% year-over-year to $67000.0; the trailing twelve-month figure through Jun 2026 stood at $656000.0 (down 40.69% YoY), and the FY2024 full-year result was $1.1 million, up 139.86% from the prior year.
• Interest Expenses held at $67000.0 in Q2 2026 per IBO's latest filing, from $67000.0 in the prior quarter.
• Across five years, Interest Expenses topped out at $305000.0 in Q3 2024 and bottomed at $67000.0 in Q1 2026.
• Historically, Interest Expenses has averaged $172937.5 across 5 years, with a median of $132000.0 in 2022.
• The sharpest annual moves came in 2024 and 2026: Interest Expenses jumped 199.02% in 2024, then plunged 75.28% in 2026.
• Over 5 years, Interest Expenses stood at $99000.0 in 2022, then gained by 26.26% to $125000.0 in 2023, then surged by 116.0% to $270000.0 in 2024, then declined by 2.96% to $262000.0 in 2025, then slumped by 74.43% to $67000.0 in 2026.
• According to Business Quant data, Interest Expenses over the past three periods registered $67000.0, $67000.0, and $262000.0 for Q2 2026, Q1 2026, and Q3 2025 respectively.